GERM

Amplify Treatments, Testing and Advancements ETF
GERM

Delisted

GERM was delisted on the 5th of September, 2024.

Back to rankings

11 hedge funds and large institutions have $1.43M invested in Amplify Treatments, Testing and Advancements ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$221K
2
+$98K
3
+$19

Top Sellers

1
-$9.12K
2
-$3.64K
3
-$3K
4
Osaic Holdings
Osaic Holdings
Arizona
-$2.11K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$850K
2
$515K
3
$27.3K
4
$8.87K
5
$6K
6
$5.08K
7
$4.28K
8
$4.21K
9
$3.64K
10
$2.91K
11
$19